NCT06429787
- Conditions
- Significant Bleeding Risk, Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1, Vitamin K-Dependent Coagulation Defect
- Locations
-
- Octapharma Research Site Boston, Massachusetts, United States
Clinical trial condition
Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1
Explore clinical trials studying Vitamin K-Dependent Clotting Factors, Combined Deficiency Of, 1. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study